The clinical diagnosis of AD is based on clinical assessment as well as instrumental and laboratory findings, which include the measurement of several CSF biomarkers, including Aβ1-42, Aβ1-40, t-tau, and p-tau. The gene discussed is MAPT; the disease is Alzheimer disease.